January-GeneMind Biosciences completed tens of millions of A+ round financing, accelerating the promotion of single-molecule gene sequencing platform applications.
May-GeneMind Biosciences’new coronavirus SARS-CoV-2 nucleic acid detection kit based on fluorescent PCR and single-molecule fluorescent sequencing has been successively approved by the European Union CE certification.
September-Completed 140 million of B-round financing. Expanded sequencing applications.
October-Genemind released new sequencing platform – GenoLab in special product launch event.